TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73

Benzinga Newsdesk www.benzinga.com Negative 74.0%

Neg 74% Neu 0% Pos 0%

TD Cowen analyst Kyle Boucher downgrades Bio-Techne (NASDAQ:TECH) from Buy to Hold and raises the price target from $65 to $73.